WO2001043725A1 - Controlled release kci tablet formulations - Google Patents
Controlled release kci tablet formulations Download PDFInfo
- Publication number
- WO2001043725A1 WO2001043725A1 PCT/US2000/033924 US0033924W WO0143725A1 WO 2001043725 A1 WO2001043725 A1 WO 2001043725A1 US 0033924 W US0033924 W US 0033924W WO 0143725 A1 WO0143725 A1 WO 0143725A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- weight
- ethylcellulose
- potassium chloride
- tablet
- parts
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU21013/01A AU2101301A (en) | 1999-12-16 | 2000-12-15 | Controlled release kci tablet formulations |
EP00984388A EP1244429A1 (en) | 1999-12-16 | 2000-12-15 | Controlled release kci tablet formulations |
CA002394588A CA2394588A1 (en) | 1999-12-16 | 2000-12-15 | Controlled release kcl tablet formulations |
HK03102222.3A HK1051320A1 (en) | 1999-12-16 | 2003-03-27 | Controlled release kci tablet formulations |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US46508599A | 1999-12-16 | 1999-12-16 | |
US09/465,085 | 1999-12-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2001043725A1 true WO2001043725A1 (en) | 2001-06-21 |
Family
ID=23846434
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/033924 WO2001043725A1 (en) | 1999-12-16 | 2000-12-15 | Controlled release kci tablet formulations |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1244429A1 (en) |
AU (1) | AU2101301A (en) |
CA (1) | CA2394588A1 (en) |
HK (1) | HK1051320A1 (en) |
WO (1) | WO2001043725A1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7632521B2 (en) * | 2003-07-15 | 2009-12-15 | Eurand, Inc. | Controlled release potassium chloride tablets |
EP2389174A2 (en) * | 2009-01-22 | 2011-11-30 | Abbot Healthcare Private Limited | Chronotherapeutic pharmaceutical composition |
EP2601936A1 (en) * | 2010-08-03 | 2013-06-12 | Eisai R&D Management Co., Ltd. | Compressed composition |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117122701B (en) * | 2023-08-15 | 2024-04-19 | 河北三禾实创生物科技有限公司 | Potassium chloride granule preparation and preparation method thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4716041A (en) * | 1984-02-10 | 1987-12-29 | A/S Alfred Benzon | Diffusion coated multiple-units dosage form |
US5397574A (en) * | 1993-10-04 | 1995-03-14 | Andrx Pharmaceuticals, Inc. | Controlled release potassium dosage form |
US5422122A (en) * | 1992-08-04 | 1995-06-06 | Eurand America, Incorporated | Controlled release potassium chloride tablet |
US5840329A (en) * | 1997-05-15 | 1998-11-24 | Bioadvances Llc | Pulsatile drug delivery system |
-
2000
- 2000-12-15 WO PCT/US2000/033924 patent/WO2001043725A1/en not_active Application Discontinuation
- 2000-12-15 EP EP00984388A patent/EP1244429A1/en not_active Withdrawn
- 2000-12-15 AU AU21013/01A patent/AU2101301A/en not_active Abandoned
- 2000-12-15 CA CA002394588A patent/CA2394588A1/en not_active Abandoned
-
2003
- 2003-03-27 HK HK03102222.3A patent/HK1051320A1/en unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4716041A (en) * | 1984-02-10 | 1987-12-29 | A/S Alfred Benzon | Diffusion coated multiple-units dosage form |
US5422122A (en) * | 1992-08-04 | 1995-06-06 | Eurand America, Incorporated | Controlled release potassium chloride tablet |
US5397574A (en) * | 1993-10-04 | 1995-03-14 | Andrx Pharmaceuticals, Inc. | Controlled release potassium dosage form |
US5840329A (en) * | 1997-05-15 | 1998-11-24 | Bioadvances Llc | Pulsatile drug delivery system |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7632521B2 (en) * | 2003-07-15 | 2009-12-15 | Eurand, Inc. | Controlled release potassium chloride tablets |
EP2389174A2 (en) * | 2009-01-22 | 2011-11-30 | Abbot Healthcare Private Limited | Chronotherapeutic pharmaceutical composition |
EP2389174A4 (en) * | 2009-01-22 | 2014-05-07 | Abbot Healthcare Private Ltd | Chronotherapeutic pharmaceutical composition |
EP2601936A1 (en) * | 2010-08-03 | 2013-06-12 | Eisai R&D Management Co., Ltd. | Compressed composition |
EP2601936A4 (en) * | 2010-08-03 | 2014-03-19 | Eisai R&D Man Co Ltd | Compressed composition |
Also Published As
Publication number | Publication date |
---|---|
EP1244429A1 (en) | 2002-10-02 |
CA2394588A1 (en) | 2001-06-21 |
AU2101301A (en) | 2001-06-25 |
HK1051320A1 (en) | 2003-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4968508A (en) | Sustained release matrix | |
US4816264A (en) | Sustained release formulations | |
EP0660705B1 (en) | Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine | |
US4610870A (en) | Controlled release formulation | |
US6476006B2 (en) | Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonates | |
EP0280571B1 (en) | Sustained release matrix formulations | |
US20040052844A1 (en) | Time-controlled, sustained release, pharmaceutical composition containing water-soluble resins | |
US20030133982A1 (en) | Zero-order sustained release dosage forms and method of making same | |
US20040202718A1 (en) | Dosage form for treatment of diabetes mellitus | |
AU2001268719A1 (en) | Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonates | |
WO2001035958A1 (en) | Carvedilol methanesulfonate | |
JPH061716A (en) | Medical prescription having long-term releasability of active ingredient | |
KR20080037680A (en) | Solid pharmaceutical composition comprising 1-(4-chloroanilino)-4-(4-pyridylmethyl)phthalazine and a ph modifier | |
US5422122A (en) | Controlled release potassium chloride tablet | |
US20120003307A1 (en) | Levetiracetam controlled release composition | |
CZ298851B6 (en) | Controlled-release tablet for oral administration of active substances | |
US20100285125A1 (en) | Delivery system for poorly soluble drugs | |
US20050013860A1 (en) | Controlled release potassium chloride tablets | |
EP1216032B1 (en) | Oral controlled release formulations | |
WO2001043725A1 (en) | Controlled release kci tablet formulations | |
WO2003099214A2 (en) | Biguanide formulations | |
JP3282832B2 (en) | Sustained tablets | |
JPH06345649A (en) | Ipsapyrone pharmaceutical composition | |
US20040228918A1 (en) | Granule modulating hydrogel system | |
KR20210147955A (en) | Sustained release metformin coated tablets controlled by osmotic pressure and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2394588 Country of ref document: CA Ref document number: PA/A/2002/005994 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 519696 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000984388 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 21013/01 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 2000984388 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2000984388 Country of ref document: EP |